C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2002
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002	DE10124453A1 Preparation of biperiden used for treating Parkinson's disease, by reacting phenylmagnesium compound and exo-bicycloheptenenyl substituted propanone compound
11/21/2002	DE10124452A1 Preparation of biperiden used for treating Parkinson's disease by reacting diphenylmagnesium and bicycloheptenenyl-substituted propanone of high exo/endo ratio
11/21/2002	DE10124451A1 Preparation of biperiden used for treating Parkinson's disease, by reacting phenylmagnesium compound and bicycloheptenenyl-substituted propanone of high exo/endo ratio
11/21/2002	DE10124450A1 Preparation of biperiden used for treating Parkinson's disease by reacting phenylmagnesium compound and bicycloheptenenyl-substituted propanone of high exo/endo ratio
11/21/2002	DE10124449A1 Preparation of biperiden used for treating Parkinson's disease by reacting phenylmagnesium compound and bicycloheptenenyl substituted propanone of high exo/endo ratio
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002	CA2445922A1 Estrogen receptor modulators
11/20/2002	EP1258476A1 Alpha-amino acid derivatives, method for their preparation and their use as dipeptidyl-peptidase IV inhibitors (DPP IV)
11/20/2002	EP1257541A2 Polypharmacophoric agents
11/20/2002	EP1257264A1 Estrogen receptor modulators
11/20/2002	EP1233955A4 Process for preparing piperazine-substituted aliphatic carboxylates
11/20/2002	EP1177198B1 Bis(n,n-dihydrocarbylamino)- substituted cyclopentadienes and metal complexes thereof
11/20/2002	EP0917465B1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing the same agents
11/19/2002	US6482944 By direct reaction of an amine with an alpha, gamma-dihaloalkane or an alpha, gamma-dihaloalkene; tertiary aminoalkylorganometallics can be made by then reacting the tert haloalkylamines with an alkali metals
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482860 Pentafluorobenzenesulfonamides and analogs
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482827 Matrix metalloproteinase inhibitors
11/19/2002	CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/19/2002	CA2115143C Macromonomers having reactive end groups
11/19/2002	CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090336A1 Substituted arylketones
11/14/2002	WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002	WO2002090327A1 Piperazinyl-isatins
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002089738A2 Proteomimetic compounds and methods
11/14/2002	WO2002072524A3 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002	US20020169208 Oxybutynin analogs; antichloinergic agents; side effect reduction; short half-life; water-soluble metabolites; incontinence; mydriatic and bronchodilator agents; respiratory system disorders; antiperspirants
11/14/2002	US20020169170 Arylpiperazines having activity at the serotonin 1A receptor
11/14/2002	US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002	US20020166181 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
11/14/2002	DE10123129A1 Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel Deuterated 3-piperidinopropiophenones and pharmaceutical compositions containing them
11/14/2002	CA2449187A1 Substituted arylketones
11/14/2002	CA2446380A1 Proteomimetic compounds and methods
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes
11/13/2002	EP1255744A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof
11/13/2002	EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/12/2002	US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002	US6479662 Antitumor dibenzofluorene derivatives
11/12/2002	US6479661 Method for symmetrically and asymmetrically disubstituting carboxylic acid amides with organotitanates and grignard reagents
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479495 Simultaneously treating depression and memory dysfunction in mammals suffering from memory dysfunction and depression
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088100A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
11/07/2002	WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002	WO2002079137A8 Interleukin-1 and tumor necrosis factor-alpha modulators and their enantiomers, their synthesis and use
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002	WO2001034586A3 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
11/07/2002	US20020165411 Sterically hindered phosphine ligands and uses thereof
11/07/2002	US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002	US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254890A1 Derivatives of 3,3-diphenylpropylamines
11/06/2002	EP1254662A2 Methods and kits for treating depression or preventing deterioration of cognitive function
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476235 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476027 N-hydroxy 4-sulfonyl butanamide compounds
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6475247 Naphthalene cationic coupler for oxidation dyeing of keratin fiber
11/05/2002	CA2091248C Diphenylpiperazine derivative and drug for circulatory organ containing the same
10/2002
10/31/2002	WO2002085871A2 Serotonergic agents with long-acting in vivo effects
10/31/2002	WO2002085865A1 A method for the preparation of oxazolidinones
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085303A2 Substituted tetracycline compounds for the treatment of malaria
10/31/2002	WO2002076918A8 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
10/31/2002	WO2002068390A8 Diamides which inhibit tryptase and factor xa activity
10/31/2002	WO2002068381A3 Aryl-n-cyanoguanidines and methods related thereto
10/31/2002	WO2002048072A3 Organic reactions with co generating materials
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa

1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 341